Related Experiment Videos
Phosphoprotein, protein kinase C, and second-messenger system changes in human multidrug-resistant cancer cells
Cancer Treatment and Research
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Overview of the early campaign diagnostics for the SPARC tokamak (invited).
The Review of scientific instruments·2024
Overview of the neutron diagnostic systems for the SPARC tokamak.
The Review of scientific instruments·2024
Ion optical design of the magnetic proton recoil neutron spectrometer for the SPARC tokamak.
The Review of scientific instruments·2024
Design solutions for the hodoscope of the magnetic proton recoil neutron spectrometer of the SPARC tokamak.
The Review of scientific instruments·2024
Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.
Physical review letters·2024
Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.
Physical review letters·2022
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Pharmacological management of obesity: Current landscape and emerging therapies.
Indian journal of pharmacology·2026
Engineered human adipose-derived stem cells delivering carboxylesterase and TRAIL for castration-resistant prostate cancer: Translational synthesis.
Investigative and clinical urology·2026
Synergistic effects of sorafenib and cilostazol in HepG2 cells.
Journal of biosciences·2026
Mechanisms and therapeutic opportunities of the ribotoxic stress response in cancer.
Molecular oncology·2026